Here, we provided sufficient evidence to demonstrate that RNF38 promotes HCC progression; notably, cells with high levels of RNF38 tended to exhibit the mesenchymal phenotype both in vitro and in vivo. This evidence concerns the gene RNF38 and hepatocellular carcinoma.